Skip to content

Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep

Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02304900
Acronym
IOL et sommeil
Enrollment
400
Registered
2014-12-02
Start date
2009-12-31
Completion date
2012-12-31
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

cataract

Brief summary

The cataract surgery (550 000 operations per year in France) is to replace the cloudy lens with a refractive implant. Two colors of implants are available: white implants, filtering out ultraviolet and yellow implants, filtering and more blue light. No clinical data are available to assert the superiority of an implant according to its color and the choice is made according to the preference of the surgeon and / or markets. It is established in humans that blue light has an important role on the secretion of melanopsin, a key mediator of the circadian cycle. This clock regulates most neuroendocrine functions in the nycthémère (sleep, mood, temperature, cortisol, ..). The question of the impact of these neuro endocrine functions of the installation of a blue light filter into the eyes of patients operated thus arises.

Interventions

OTHERwhite implant

1. st intervention (in the month following the inclusion): Randomization of the color of the implant 2. nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye

OTHERyellow implant

1. st intervention (in the month following the inclusion): Randomization of the color of the implant 2. nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye

Sponsors

University Hospital, Tours
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* female or male subject * subject between 60 and 90 years old * Visual acuteness \< or = with 2 eyes * Indication operating of the cataract

Exclusion criteria

* NA

Design outcomes

Primary

MeasureTime frame
Variation between before and 2 months after surgery sleep time2 months

Secondary

MeasureTime frame
Variation between before and 2 months after surgery the number of hours of sleep2 months
Variation between before and 2 months after surgery of the quality of sleep2 months
Variation between before and 2 months after surgery the mood evaluation score2 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026